58 results
Page 2 of 3
8-K
EX-99.1
q5ot9o2
7 Aug 23
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Return of Capital to Shareholders
7:38am
8-K
EX-99.1
xya4e6zhmp3 xy
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
5k9n1565u245hwo9
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.2
wakncu6ns
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.1
g37 72p4dvef6c7fd
8 May 23
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Return of Capital to Shareholders
7:51am
SC TO-T
EX-99
rv45vws2
1 Dec 22
Third party tender offer statement
6:06am
SC TO-T
csv12 rhpghqk58gy
1 Dec 22
Third party tender offer statement
6:06am
SC TO-C
EX-99.1
r2eijk6 qanbk2
8 Nov 22
Information about tender offer
6:06am
SC TO-C
EX-99.2
ux9wu y2w31
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.1
3c8904 z6m
7 Nov 22
Information about tender offer
5:26pm
8-K
EX-99.1
fymhydf1tmif8af0r
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.2
qcs0leu yuun
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
DEF 14A
vrmqn9 szry0
29 Oct 21
Definitive proxy
4:35pm